查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464979

Biperiden市场：按剂量、按应用 - 全球预测 2024-2030

Biperiden Market by Administration (Injection, Oral), Application (Drug-induced Movement Disorders, Parkinson Disease, Touret Syndrome) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年比Biperiden市场规模为3.6427亿美元，2024年将达3.847亿美元，2030年将达5.3676亿美元，复合年增长率为5.69%。

Biperiden是一种药物化合物，被归类为抗胆碱能药物，主要用于其抗痉挛和抗帕金森氏症作用。它透过阻断中枢和周围神经系统中的乙酰胆碱受体来发挥作用。这一动作有助于减轻与帕金森氏症相关的症状，例如僵硬、颤抖和唾液分泌过多。此外，Biperiden也用于抵消抗精神病药物的副作用，例如不自主的肌肉运动。多种剂型，包括口服和注射製剂，可灵活给药以满足患者需求。与所有药物一样，Biperiden的使用必须在医疗专业人员的指导下严格控制，以平衡治疗效果和潜在副作用。全球帕金森氏症患者数量的不断增加正在推动Biperiden的需求。老年人口的成长推动了Biperiden的需求增加，因为老年人更容易罹患帕金森氏症。此外，提高Biperiden疗效并减少副作用的持续研究也促进了市场的成长。然而，Biperiden具有抗胆碱能副作用，例如口干、视力模糊和便秘，这可能限制其在某些患者中的使用。然而，开发具有改进的递送机制、减少的副作用和提高的患者依从性的比Biperiden製剂提供了巨大的机会。随着医疗保健支出不断增加和患者群体开拓，向新兴市场扩张具有巨大的成长潜力。

主要市场统计
基准年[2023] 3.6427 亿美元
预测年份 [2024] 3.847 亿美元
预测年份 [2030] 53676万美元
复合年增长率（%） 5.69%

易于给药和患者依从性增加了对口服给药的偏好

Biperiden登注射液主要用于无法口服给药的急性病症的快速症状控制。注射剂是治疗急性肌张力失调反应的有效方法，因为它们的血浆浓度很快就达到高峰。这种给药途径需要医疗保健专业人员的密切给药和监测，以减少抗胆碱能副作用等潜在风险。Biperiden因其易于使用和患者依从性而被广泛用于长期管理。它以锭剂形式提供，可缓释药物并全天保持稳定的血浆浓度。这种方法适用于治疗慢性病，并允许患者以最少的干扰维持规律的日常生活。

应用实例 比Biperiden作为有效抗胆碱能药物在药物引起的运动障碍中的增殖

Biperiden是一种强效抗胆碱能药物，常用于治疗药物引起的运动障碍 (DIMD)。 DIMD 通常是抗精神病药物的副作用，抗精神病药物主要用于治疗各种精神疾病。这些运动障碍表现为肌张力不全症、静坐不能、帕金森氏症和迟发性。Biperiden透过阻断乙酰胆碱受体来矫正抗精神病药物引起的大脑神经传导物质失衡。它可以缓解肌肉僵硬、震颤和不自主肌肉运动等症状，显着改善 DIMD 患者的生活品质。帕金森氏症是退化性疾病。透过拮抗乙酰胆碱的作用，Biperiden登恢復大脑中多巴胺和乙酰胆碱之间的平衡。这种调整有助于缓解与帕金森氏症相关的运动症状，但它不会逆转疾病的进展或影响非运动症状。妥瑞症是一种神经系统疾病，会导致重复性、常规性不自主运动和发声，称为抽动。妥瑞症的疗效很大程度上取决于患者个体对药物的反应和症状的性质。Biperiden的抗胆碱能作用可能有助于缓解某些运动抽搐，但临床医生必须仔细权衡其益处和潜在副作用。

区域洞察

美洲Biperiden市场的特点是医疗基础设施强大、对神经系统疾病的认知度高以及监管支持有力。美国是该地区最大的市场，由于人口老化以及帕金森氏症和锥体外系症状的流行，需求量很大。监管核准和保险覆盖政策对该地区的市场动态产生重大影响。此外，由于医疗设施的改善、医疗成本的上升以及对神经系统疾病的认识的提高，拉丁美洲显示出广泛的成长潜力。在欧洲、中东和非洲地区，欧洲因其先进的医疗体系、高昂的医疗费用以及帕金森氏症患者病率的上升而成为Biperiden登的核心市场。老牌製药公司的存在和有利的法规环境进一步推动了市场的发展。由于人口快速增长、医疗保健需求增加以及帕金森氏症和其他相关疾病盛行率的增加，亚太地区正在经历有利的市场条件。中国、印度等国家因其庞大的人口基数和快速发展的医疗保健产业而占据着举足轻重的地位。医疗基础设施投资的增加、中阶人口的增长以及对神经系统疾病的认识不断提高是推动该地区市场的关键因素。

FPNV定位矩阵

FPNV定位矩阵对于评估比Biperiden市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可以对Biperiden市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析也为此细分市场的竞争特征提供了宝贵的见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：包括新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：包括对未来技术、研发活动和突破性产品开发的智力见解。

本报告解决了以下关键问题：

1.Biperiden市场的市场规模和预测是多少？

2.在Biperiden市场预测期内需要考虑投资的产品、细分市场、应用和细分市场有哪些？

3. Biperiden市场的技术趋势和法规结构是什么？

4.Biperiden市场主要供应商的市场占有率是多少？

5. 进入Biperiden市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球Biperiden登治疗巴金森氏症的使用量增加
      • 在治疗药物引起的运动障碍的药物开发中增加使用Biperiden
    • 抑制因素
      • Biperiden生产认知度低、成本高
    • 机会
      • 持续研发，增强Biperiden药物的适用性
      • 製药公司对比Biperiden生产的新投资
    • 任务
      • 比Biperiden登相关的潜在健康影响
  • 市场区隔分析
    • 剂量：由于易于使用和患者依从性，口服给药越来越受欢迎
    • 用途：Biperiden作为有效抗胆碱能药物在药物引起的运动障碍的推广
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章Biperiden市场管理

  • 介绍
  • 注射
  • 口服

第七章Biperiden市场：依应用

  • 介绍
  • 药物引起的运动障碍
  • 帕金森氏症
  • 妥瑞症

第八章 美洲Biperiden市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太比Biperiden市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲Biperiden市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-351BAD503D4E

[197 Pages Report] The Biperiden Market size was estimated at USD 364.27 million in 2023 and expected to reach USD 384.70 million in 2024, at a CAGR 5.69% to reach USD 536.76 million by 2030.

Biperiden is a pharmaceutical compound classified as an anticholinergic agent, primarily utilized for its antispasmodic and antiparkinsonian properties. It operates by blocking acetylcholine receptors in the central and peripheral nervous system. This action helps in reducing the symptoms associated with Parkinson's disease, such as rigidity, tremors, and excessive salivation. Additionally, biperiden is employed to counteract the side effects of antipsychotic medications, including involuntary muscle movements. Its availability in various forms, including oral and injectable, allows for flexibility in administration based on patient needs. As with all medications, the use of biperiden must be closely managed under the guidance of a healthcare professional to balance therapeutic benefits against potential side effects. The increasing number of Parkinson's disease cases globally drives the demand for Biperiden. As older age groups are more prone to Parkinson's, the expanding elderly demographic fosters an Increasing need for biperiden. Moreover, Continuous research on improving Biperiden's efficacy and reducing side effects contributes to market growth. However, biperiden's anticholinergic side effects, such as dry mouth, blurred vision, and constipation, may limit its usability for some patients. Nevertheless, the development of biperiden formulations with improved delivery mechanisms, reduced side effects, and enhanced patient compliance presents significant opportunities. Expanding into emerging markets with increasing healthcare expenditure and untapped patient demographics offers considerable growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 364.27 million
Estimated Year [2024] USD 384.70 million
Forecast Year [2030] USD 536.76 million
CAGR (%) 5.69%

Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance

The injectable form of Biperiden is primarily used for rapid symptom control in acute episodes where oral administration is not feasible. The injectable route provides quick plasma concentration peaks, making it an efficient method for managing acute dystonic reactions. This administration route demands meticulous dosing and monitoring by healthcare professionals to mitigate potential risks such as anticholinergic side effects. Oral administration of Biperiden is widely utilized for long-term management due to its ease of use and patient compliance. Available in tablet form, it allows for a sustained release of the medication, facilitating stable plasma concentrations throughout the day. This method is preferable for managing chronic symptoms, allowing patients to maintain regular daily activities with minimal disruption.

Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent

Biperiden is a potent anticholinergic agent that is frequently used in the management of drug-induced movement disorders (DIMDs). DIMDs are often a side effect of antipsychotic medications, which are primarily used to treat various psychiatric disorders. These movement disorders can manifest as dystonia, akathisia, parkinsonism, and tardive dyskinesia. Biperiden works by blocking acetylcholine receptors, thereby correcting the imbalance of neurotransmitters in the brain caused by antipsychotic medications. It serves to alleviate symptoms such as muscle stiffness, tremors, and involuntary muscle movements, significantly improves the patients quality of life suffering from DIMDs. Parkinson's Disease depicts degenerative disorder of the central nervous system, affecting the motor system. By antagonizing the action of acetylcholine, biperiden helps restore the balance between dopamine and acetylcholine in the brain. This adjustment aids in alleviating the motor symptoms associated with Parkinson's Disease, although it does not reverse the disease progression or affect the non-motor symptoms. Tourette Syndrome is a type of neurological disorder that depicts repetitive, stereotyped, involuntary movements and vocalizations called tics. Its efficacy in Tourette Syndrome largely depends on the individual patient's response to the medication and the nature of their symptoms. The anticholinergic action of biperiden can help mitigate certain motor tics, but clinicians should carefully weigh its benefits against potential side effects.

Regional Insights

The Biperiden market in the Americas is characterized by a robust healthcare infrastructure, high awareness of neurological disorders, and strong regulatory support. The United States, being the largest market in the region, demonstrates significant demand due to an aging population and the prevalence of Parkinson's disease and extrapyramidal symptoms. Regulatory approvals and insurance coverage policies significantly influence the market dynamics in this region. Furthermore, Latin America shows promising growth potential, attributed to improving healthcare facilities, rising healthcare expenditures, and increasing awareness of neurological disorders. In the EMEA region, Europe stands out as a central market for biperiden, supported by its advanced healthcare systems, high spending on healthcare, and an increasing incidence of Parkinson's disease. The presence of well-established pharmaceutical companies, coupled with favorable regulatory environments, further drives the market. The Asia Pacific region shows an opportunistic landscape for the growth of the biperiden market, driven by burgeoning populations, escalating healthcare needs, and increasing prevalence of Parkinson's disease and other related disorders. Countries including China and India are pivotal due to their immense population base and rapidly evolving healthcare sectors. Increased investments in healthcare infrastructure, growing middle-class populations, and rising awareness about neurological disorders are key factors propelling the market in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biperiden Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biperiden Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biperiden Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., ACTYLIS, Adooq Bioscience LLC, BioCrick BioTech, Biotechne Corporation, Clearsynth, Enomark, MANUS AKTTEVA BIOPHARMA LLP, Merck KGaA, NIKSAN PHARMACEUTICAL, Rafa Laboratories Ltd., SAKHIYA PHARMA CHEM, Salvavidas Pharmaceutical Pvt. Ltd., Shreeji Pharma International, Simson Pharma, and Synnat Pharma.

Market Segmentation & Coverage

This research report categorizes the Biperiden Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Administration
    • Injection
    • Oral
  • Application
    • Drug-induced Movement Disorders
    • Parkinson Disease
    • Touret Syndrome
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biperiden Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biperiden Market?

3. What are the technology trends and regulatory frameworks in the Biperiden Market?

4. What is the market share of the leading vendors in the Biperiden Market?

5. Which modes and strategic moves are suitable for entering the Biperiden Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of biperiden to treat parkinson's disease globally
      • 5.1.1.2. Rising usage of biperiden in drug developement of drug-induced movement disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and high cost of biperiden manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development to enhance the applicability of biperiden-based drugs
      • 5.1.3.2. Emerging investments by pharmaceutical companies in biperiden production
    • 5.1.4. Challenges
      • 5.1.4.1. Potential health affects associated with biperiden
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance
    • 5.2.2. Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biperiden Market, by Administration

  • 6.1. Introduction
  • 6.2. Injection
  • 6.3. Oral

7. Biperiden Market, by Application

  • 7.1. Introduction
  • 7.2. Drug-induced Movement Disorders
  • 7.3. Parkinson Disease
  • 7.4. Touret Syndrome

8. Americas Biperiden Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biperiden Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biperiden Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Merck Seals USD 610 Million Biobucks Deal to Acquire Preclinical Neurodegenerative Biotech Caraway
    • 11.3.2. AbbVie Acquires Parkinson's Drug in Latest Biotech Buyout
    • 11.3.3. Serina-AgeX Merger to Develop Treatment for Advanced Parkinson's
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIPERIDEN MARKET RESEARCH PROCESS
  • FIGURE 2. BIPERIDEN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIPERIDEN MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIPERIDEN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIPERIDEN MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 22. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 28. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 32. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 33. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 36. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 37. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 40. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 41. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 44. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 56. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 60. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 61. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 64. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 65. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 72. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 73. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 76. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 80. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 84. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 92. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 93. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 96. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 97. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 100. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 101. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 109. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 110. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 111. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 114. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 115. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 122. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 123. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 126. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 127. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 134. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 135. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 138. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 142. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 143. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 146. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 147. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 150. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 151. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 154. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 155. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 158. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 159. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 174. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 175. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 178. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023